Sanofi has secured European approval for a next-generation rabies vaccine, giving the bloc a modernised tool against one of the world’s oldest and deadliest infections. On 19 November, the French
Sanofi has secured European approval for a next-generation rabies vaccine, giving the bloc a modernised tool against one of the world’s oldest and deadliest infections. On 19 November, the French